Activity in this selectionUnited States · Oct 16, 2026 · Jul 19, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- 0
All roles disclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $52M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionZenflowA minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.
Participant